← Back to All Filings
BioNTech CEO Ugur Sahin Sells $1.97M in Ordinary Shares via Rule 10b5-1 Plan
BioNTech SE
$BNTX4CIK: 0001776985
Subscribe to track BNTX
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Issuer: BioNTech SE (BNTX)
Insider: Ugur Sahin
Title: Chief Executive Officer & 10% Owner
Transaction: Sale (Rule 10b5-1)
Shares Sold: 20,500
Price per Share: $96.31
Total Value: $1,974,287.35
Direct Shares Remaining: 688,209
Indirect Shares Remaining: 39,218,111
Date of Transaction: 2026-09-10
Comprehensive Analysis
Executive Summary
On September 10, 2026, Ugur Sahin, Chief Executive Officer and 10% owner of BioNTech SE ($BNTX), executed an open-market sale of 20,500 ordinary shares at a weighted average price of $96.3067 per share, generating gross proceeds of approximately $1.97 million.
Key Transaction Details
- Security: Ordinary Shares
- Transaction Type: Open Market Sale (Code
S) - Shares Sold: 20,500
- Execution Price: $96.3067
- Total Value: $1,974,287.35
- Pre-set Trading Plan: The transaction was executed pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on June 3, 2026.
Post-Transaction Holdings
- Direct Ownership: 688,209 ordinary shares.
- Indirect Ownership: 39,218,111 ordinary shares held via Medine GmbH (of which Ugur Sahin is the sole shareholder).
- Impact: The shares sold represent a minor fraction (less than 0.1%) of Dr. Sahin's total combined direct and indirect beneficial ownership of over 39.9 million shares.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.